高分文献速递
客户单位:上海交通大学医学院附属第六人民医院
期刊:Advanced Healthcare Materials
影响因子(IF):10
文章题目:
Exercise mimetic exosomes re-establish the extracellular matrix metabolic balance and alleviate the inflammatory macrophage infiltration in intervertebral disc degeneration
文章摘要:
Extracellular matrix (ECM) metabolic imbalance and macrophage infiltration, induced by degenerated nucleus pulposus cells (NPCs), represent key pathological alterations in intervertebral disc degeneration (IVDD). Physical exercise is shown to effectively delay the progression of IVDD by enhancing ECM synthesis and reducing inflammation. However, many individuals are unable to maintain regular exercise habits due to physical limitations and insufficient self-discipline. In response to this challenge, the concept of exercise mimetic exosomes (EMEs) is proposed as a therapeutic strategy for IVDD. In this approach, human induced pluripotent stem cell-derived myotubes are subjected to mechanical strain to simulate exercise conditions. The exosomes generated under these conditions, termed EMEs, are enriched with exercise-inducible components, notably irisin. These EMEs are capable of being internalized by both NPCs and macrophages. In NPCs, EMEs restored ECM metabolic balance and inhibited NFκB activation. In macrophages, EMEs modulated the M1 polarization induced by degenerated NPCs. Collectively, EMEs restored the metabolic equilibrium of the extracellular matrix and mitigated inflammatory macrophage infiltration within the microenvironment, thereby demonstrating significant therapeutic effects on IVDD. More importantly, EMEs may serve as a model for the treatment of other musculoskeletal disorders and the development of exercise mimetic therapies.
原文链接:
https://doi.org/10.1002/adhm.202500219
引用产品及培养细胞:FBS-303 大鼠骨髓原代巨噬细胞
SCI
助力科研·一路同行
2025 SCI论文奖励活动全新升级
|
影响因子(IF) |
新奖励方案 |
升级体验 |
|
IF<20 |
¥50元京东卡 |
①赠送常规科研用细胞1株(STR鉴定正确) ②额外获得「科研助力礼包」 (含有优先供货 + 技术咨询快速通道) |
|
IF≥20 |
¥2000元京东卡 |
①赠送常规科研用细胞1株(STR鉴定正确) ②额外获得「科研助力礼包」 (含有优先供货 + 技术咨询快速通道) ③授予 "年度科研协作伙伴" 称号 |
注:影响因子(IF)以2025年公布的数据为准
细胞清单,扫码查看
· ·奖励对象及规则 · ·
(新计划活动时间 )
2025年05月01日-2025年12月31日
1.奖励对象
使用金源康生物胎牛血清产品FBS-300、FBS-301、FBS-303,并在SCI期刊杂志发表文章,且文章正文中在使用产品的位置标注相应产品型号及我公司名“Inner Mongolia Jinyuankang Biotechnology Co., Ltd”或“Jin Yuan Kang Biotechnology”均可参与本次活动。
2. 奖励说明
1) 申请人论文已发表三个月内,且为第一作者或通讯作者,第一作者与通讯作者同时申请,以通讯作者为准;同一申请人若有多篇见刊论文引用同一产品,则按最高影响因子所在档实施单次最大奖励,不予重复奖励;
2) 提供文献全文(PDF格式)以及文章链接,并同意在金源康及其旗下子品牌后续推广展示;
3) 每篇文献仅限领取一次奖励;
4) 影响因子(IF)以申请奖励时间为准;
5) 试用装产品,不参与活动奖励;
6) 经公司审核通过后,我们会尽快与申请人联系,确定购物卡及赠送细胞的派发。
· ·活动参与方式 · ·
参与方式一
扫描下方二维码,填写问卷,7个工作日内,工作人员将与您联系。
完整填写信息丨申请文献奖励
参与方式二
扫描下方二维码,关注“金源康生物”微信公众号。
“金源康生物”微信公众号
回复“文献奖励”关键词,弹出问卷链接,完成问卷填写并提交。
参与方式三
关注“金源康生物”微信公众号,点击如图所示【文献奖励报名】菜单栏,可直接申请。

